眼科生物科技公司“拨康视云”,递交招股书,拟香港上市,瑞银、建银、华泰联席保荐

市场资讯
03 Dec 2024

来源:瑞恩资本RyanbenCapital2024年12月2日,Cloudbreak Pharma Inc.(简称“拨康视云”)向港交所递交招股书,拟香港主板挂牌上市。这是继其于2023年11月30日、2024年5月31日递表失效后的再一次申请。拨康视云招股书链接:https://www1.hkexnews.hk/app/sehk/2024/106945/documents/...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10